Statistics for Aldeyra Therapeutics (id:5317 ALDX)
Valuation metrics
Market cap
279.88M
Enterprise value
193.57M
Trailing P/E (ttm)
-7.58
Forward P/E
-7.70
PEG ratio
-7.70
Price/Sales (ttm)
Price/Book (mrq)
3.29
Enterprise Value/Revenue
Enterprise Value/EBITDA
-3.92
Overview
Shares outstanding
59.55M
Float
43.26M
Shares short
3.67M
% Held by insiders
0.02%
% Held by institutions
0.62%
Average volume (10 days)
690.77K
Average volume (90 days)
Price summary
52-Week low
2.43
52-Week high
6.55
52-Week change
47.84%
Beta
1.43
50-Day moving average
5.45
200-Day moving average
4.30
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-23.45%
Return on equity
-43.05%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-49,385,308.00
Net income to common (ttm)
-44,795,640.00
Diluted EPS (ttm)
-0.75
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
72.74M
Total cash per share (mrq)
1.22
Total debt (mrq)
15.61M
Total Debt/Equity (mrq)
18.35
Current ratio (mrq)
680.50%
Book value per share (mrq)
1.43
Cash flow
Cash flow statement
-30,671,462.00
Levered free cash flow (LFCF)
-57,674,432.00